Literature DB >> 11220550

Cosegregation of obesity with familial aggregation of type 2 diabetes mellitus.

A Ramachandran1, C Snehalatha, K Satyavani, S Sivasankari, V Vijay.   

Abstract

OBJECTIVE: We have shown that a positive family history of diabetes, and the variables of general and central obesity are independent risk factors for type 2 diabetes in our population. This study was done to evaluate whether a familial predisposition to diabetes resulted in a tendency for adverse anthropometric and haemodynamic profiles in south Indian non-diabetic subjects.
METHODS: The analysis was carried out on 2463 subjects (M: F, 1196: 1267) with normal glucose tolerance (NGT). The study subjects were selected from population surveys for diabetes. Details of age, sex, family history of diabetes, body mass index (b.m.i.), waist-to-hip ratio (WHR) and blood pressure were recorded. Serum cholesterol and triglycerides were estimated.
RESULTS: A positive family history of diabetes was present in 24.7% of our subjects. Mean b.m.i. and percentage of obesity were significantly higher in families with a positive family history (group 2) vs. families with no family history (group 1). Subjects in group 2 had a higher 2-h plasma glucose (p < 0.001) and higher prevalence of hypertension (chi2 = 6.91, p = 0.0086). Factor analysis with principle components analysis (PCA) showed that a family history of diabetes clustered with WHR in men, and with b.m.i. and WHR in women. The b.m.i. formed a different domain with blood pressure in both sexes. WHR and b.m.i. clustered with cholesterol and triglycerides in another domain.
CONCLUSIONS: In this population, general and central obesity are associated with a family history of diabetes. A family history of diabetes may increase the risk of hypertension and hyperlipidaemia indirectly through its connection with b.m.i.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11220550     DOI: 10.1046/j.1463-1326.2000.00067.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  9 in total

1.  Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease.

Authors:  Allison B Goldfine; Clara Bouche; Robert A Parker; Caroline Kim; Amy Kerivan; J Stuart Soeldner; Blaise C Martin; James H Warram; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

2.  Factor analysis of risk variables associated with metabolic syndrome in adult Asian Indians.

Authors:  Mithun Das; Susil Pal; Arnab Ghosh
Journal:  J Cardiovasc Dis Res       Date:  2010-04

3.  Effects of gender and height on the oral glucose tolerance test: the isfahan diabetes prevention study.

Authors:  Mohsen Janghorbani; Massoud Amini
Journal:  Rev Diabet Stud       Date:  2008-11-10

4.  First-degree relatives of patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver disease.

Authors:  Atoosa Adibi; Mohsen Janghorbani; Sanaz Shayganfar; Masoud Amini
Journal:  Rev Diabet Stud       Date:  2008-02-10

5.  Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study.

Authors:  Mohsen Janghorbani; Masoud Amini
Journal:  Rev Diabet Stud       Date:  2012-02-10

6.  Diabetes and impaired glucose regulation in first-degree relatives of patients with type 2 diabetes in isfahan, iran: prevalence and risk factors.

Authors:  Masoud Amini; Mohsen Janghorbani
Journal:  Rev Diabet Stud       Date:  2007-11-10

7.  A hospital-based observational study of type 2 diabetic subjects from Gujarat, India.

Authors:  Mayur Patel; Ina M Patel; Yash M Patel; Suresh K Rathi
Journal:  J Health Popul Nutr       Date:  2011-06       Impact factor: 2.000

8.  Severity of the metabolic syndrome as a predictor of prediabetes and type 2 diabetes in first degree relatives of type 2 diabetic patients: A 15-year prospective cohort study.

Authors:  Rokhsareh Meamar; Masoud Amini; Ashraf Aminorroaya; Maryam Nasri; Majid Abyar; Awat Feizi
Journal:  World J Diabetes       Date:  2020-05-15

9.  Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relatives with T2DM.

Authors:  Xu Wu; Yashan Li; Baohua Man; Dexuan Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-29       Impact factor: 3.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.